Atlantic Edge Private Wealth Management’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$9.48K Hold
75
﹤0.01% 425
2026
Q1
$10.5K Hold
75
﹤0.01% 378
2025
Q4
$9.21K Hold
75
﹤0.01% 388
2025
Q3
$8.32K Hold
75
﹤0.01% 386
2025
Q2
$8.32K Buy
+75
New +$7.98K ﹤0.01% 382

Other funds holding GILD

Atlantic Edge Private Wealth Management's GILD Position: Q2 2026 in Review

Atlantic Edge Private Wealth Management held its Gilead Sciences (GILD) position steady in Q2 2026 at 75 shares worth $9.48K. The position accounts for ﹤0.01% of the portfolio, ranked #425.

Atlantic Edge Private Wealth Management first reported a position in GILD in Q2 2025 and has held it in 5 quarters since. The position peaked at $10.5K in Q1 2026. 1,032 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Atlantic Edge Private Wealth Management held 75 shares of Gilead Sciences worth $9.48K as of Q2 2026.
  • Atlantic Edge Private Wealth Management left its Gilead Sciences share count unchanged in Q2 2026.
  • Gilead Sciences made up ﹤0.01% of Atlantic Edge Private Wealth Management's portfolio in Q2 2026, its #425 holding.
  • Atlantic Edge Private Wealth Management first reported a position in Gilead Sciences in Q2 2025 and has held it in 5 quarters since.
  • Atlantic Edge Private Wealth Management's Gilead Sciences position peaked at $10.5K in Q1 2026.
  • 1,032 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Atlantic Edge Private Wealth Management's 13F filing for Q2 2026, filed 23 Jul 2026.